The University of Ferrara is the main university of the city of Ferrara in the Emilia-Romagna region of northern Italy. In the years prior to the First World War the University of Ferrara, with more than 500 students, was the best attended of the free universities in Italy.

During the past decade, Universita di Ferrara conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universita di Ferrara" #1 sponsor was "Università degli Studi di Ferrara" with 8 trials, followed by "European Institute of Oncology" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita di Ferrara" #1 collaborator was "Università degli Studi di Ferrara" with 3 trials as a collaborator, "Federico II University" with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "ASL Parma" with 1 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Universita di Ferrara" are "Leukemia" (4 trials), "Acromegaly" (2 trials), "Acute Kidney Injury" (2 trials), "Anemia" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Universita di Ferrara" in a lesser frequency.

Most popular intervention types in "Universita di Ferrara" are "Drug" (13 trials), "Procedure" (12 trials), "Other" (5 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "etoposide" (3 trials), "gemtuzumab ozogamicin" (2 trials), "idarubicin" (2 trials) and "mitoxantrone hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universita di Ferrara" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Universita di Ferrara". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Universita di Ferrara, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universita di Ferrara, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

Universita di Ferrara has several departments that took part in Clinical trials: "Dipartimento di Medicina Clinica e Sperimentale Sezione di Pediatria Università di Ferrara" - 3 trials, "UNIVERSITà DEGLI STUDI DI FERRARA, CLINICA DI MALATTIE DELL'APPARATO RESPIRATORIO" - 2 trials